Skip to main content
. 2022 Oct 4;30(2):237–249. doi: 10.1038/s41418-022-01059-z

Fig. 3. Most promising TRAIL-comprising combination therapies as an effective means of treating cancers.

Fig. 3

Schematic presentation of the mechanism of action of the combinations of TRAIL with inhibitors of the proteasome, SMAC mimetics, BH3 mimetics or inhibitors of cyclin-dependent kinase 9 (CDK9).